Single, high-dose intramuscular triamcinolone acetonide versus weekly oral methotrexate in life-threatening asthma: A double-blind study

American Journal of Respiratory and Critical Care Medicine

Volumn 152, Issue 5 I, 1995, Pages 1461-1466

  Ogirala, Raja G ^a,b   Sturm, Toni M ^a   Aldrich, Thomas K ^a   Meller, Fiona F ^a   Pacia, Ellen B ^a   Keane, Anne Marie ^a   Finkel, Richard I ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; DIURETIC AGENT; METHACHOLINE; METHOTREXATE; ORAL ANTIDIABETIC AGENT; PLACEBO; PREDNISONE; STEROID; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0028827729     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.152.5.7582277     Document Type: Article

References (27)

1. Buist, A. S., and W.M. Vollmer. 1990. Reflections on the rise in asthma morbidity and mortality (Editorial). J.A.M.A. 264:1719-1720.
2. Mullarkey, M. F., B. A. Blumenstein, W. P. Andrade, G. A. Bailey, I. Olason, and C. E. Wetzel. 1988. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. N. Engl. J. Med. 318:603-607.
3. Mullarkey, M. F., J. K. Lammert, and B. A. Blumenstein. 1990. Long-term methotrexate treatment in corticosteroid-dependent asthma. Ann. Intern. Med. 112:577-581.
4. Shiner, R. J., A. J. Nunn, K. F. Chung, and D. M. Geddes. 1990. Randomized, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet 336:137-140.
5. Erzurum, S. C., J. A. Leff, J. E. Cochran, L. M. Ackerson, S. J. Szefler, R. J. Martin, and G. R. Scott. 1991. Lack of benefit of methotrexate in severe, steroid-dependent asthma. Ann. Intern. Med. 114:353-360.
6. Ogirala, R. G., T. K. Aldrich, D. J. Prezant, M. J. Sinnett, J. B. Enden, and M. H. Williams, Jr. 1991. High-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma. N. Engl. J. Med. 324:585-589.
7. McGivney, S. A., and R. G. Ogirala. 1994. Effect of high-dose intramuscular triamcinolone in older adults with severe, chronic asthma. Lung 172:73-78.
8. Muranaka, M., T. Miyamoto, T. Shida, J. Kabe, S. Makino, H. Okumura, K. Takeda, S. Suzuki, and Y. Horiuchi. 1978. Gold salt in the treatment of bronchial asthma - a double-blind study. Ann. Allergy 40:132-137.
9. Klaustermeyer, W. B., D. T. Noritake, and F. K. Kwong. 1987. Chrysotherapy in the treatment of corticosteroid-dependent asthma. J. Allergy Clin. Immunol. 79:720-725.
10. Spector, S. L., F. H. Katz, and R. S. Farr. 1974. Troleandomycin: effectiveness in steroid-dependent asthma and bronchitis. J. Allergy Clin. Immunol. 54:367-379.
11. Nelson, H. S., D. L. Hamilos, P. R. Corsello, N. V. Levesque, A. D. Buchmeier, and B. L. Bucher. 1993. A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids. Am. Rev. Respir. Dis. 147:398-404.
12. Peake, M. D., R. M. Clayton, and P. Howard. 1979. Triamcinolone in corticosteroid-resistant asthma. Br. J. Dis. Chest 73:39-44.
13. Willey, R. F., R. J. Fergusson, D. J. Godden, G. K. Crompton, and I. W. B. Grant. 1984. Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma. Thorax 39:340-344.
14. Alexander, A. G., N. C. Barnes, and A. B. Kay. 1992. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 339: 324-328.
15. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
16. Rosenthal, R. R. 1985. Inhalation challenge in asthma. In A. P. Kaplan, editor. Allergy. Churchill Livingstone, New York. 241-253.
17. Wurthwein, G.,S. Rehder, and P. Rohdewald. 1992. Lipophilicity and receptor affinity of glucocorticoids. Pharm. Zelt. Wissensch. 137: 161-167.
18. Nadel, J. A. 1984. Inflammation and asthma. J. Allergy Clin. Immunol. 73:651-653.
19. Kaliner, M. 1984. Hypotheses on the contribution of late-phase allergic response to the understanding and treatment of allergic diseases. J. Allergy Clin. Immunol. 73:311-315.
20. Piacentini, G. L., and M. A. Kaliner. 1991. The potential roles of leukotrienes in bronchial asthma. Am. Rev. Respir. Dis. 143:S96-S99.
21. Hogg, J. C., A. L. James, and P. D. Pare, 1991. Evidence for inflammation in asthma. Am. Rev. Respir. Dis. 143:S39-S42.
22. Svedmyr, N. 1990. Action of corticosteroids on beta-adrenergic receptors. Clinical aspects. Am. Rev. Respir. Dis. 141:S31-S38.
23. Williams, T. J., and H. Yarwood. 1990. Effect of glucocorticosteroids on microvascular permeability. Am. Rev. Respir. Dis. 141:S39-S43.
24. Lundgren, J. D., M. A. Kaliner, and J. H. Shelhamer. 1990. Mechanisms by which glucocorticosteroids inhibit secretion of mucus in asthmatic airways. Am. Rev. Respir. Dis. 141:S52-S58.
25. Schleimer, R. P. 1990. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am. Rev. Respir. Dis. 141:S59-S69.
26. Barnes, P. J. 1990. Effect of corticosteroids on airway hyperresponsiveness. Am. Rev. Respir. Dis. 141:S70-S76.
27. Bolton, W. K., and W. G. Couser. 1979. Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis. Am. J. Med. 66:495-502.